---
title: "Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study | BMEA Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288912285.md"
description: "Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study | BMEA Stock News"
datetime: "2026-06-05T15:35:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288912285.md)
  - [en](https://longbridge.com/en/news/288912285.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288912285.md)
---

# Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study | BMEA Stock News

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study | BMEA Stock News

### Related Stocks

- [BMEA.US](https://longbridge.com/en/quote/BMEA.US.md)

## Related News & Research

- [Biomea Fusion doses first patient in OPAL trial of icovamenib plus semaglutide for obesity](https://longbridge.com/en/news/295786405.md)
- [Biomea Fusion Q2 loss narrows, cash runway into Q2 2027](https://longbridge.com/en/news/295013243.md)
- [Sugar Prices Rally on Continued Weather-Related Risks](https://longbridge.com/en/news/295828762.md)
- [Sugar Prices Fall Back from Wednesday’s 1.25-Year Highs](https://longbridge.com/en/news/295960318.md)
- [AEMD: Final oncology trial cohort underway, strong cash position, and expanded research into new indications](https://longbridge.com/en/news/295851387.md)